-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in targeted therapy for melanoma: a focus on MEK inhibition
April KS Salama & Kevin B Kim
Review: Clinical Trail Outcomes: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation